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SUMMARY 
Thecovalent bindingof [6,7-3H]ethinylestradiol (EE)and [6,7-3H]estrone 
(E) to liver DNA of 200 g female ratswas measured 8 h after the administra-
tion of 80 J..Lg (9.2 mCi) estrogen by gavage. The binding is 1.5 for EE and 
1.1 for E, expressedas binding to DNA/dose, in units of ~mol hormonefmol 
DNA phosphate/mmole honnone/kg body wt. It is in the same order of 
magnitude as for benzene and about 10 000 tim es below the binding of 
typical liver carcinogens, such as aflatoxin B1 or N,N-dimethylnitrosamine. 
INTRODUCTION 
Since 1973, several reports indicate that adenomas ofthe liver may occur 
in women taking oral contraceptives [ 1] , and long-term toxicity studies in 
the beagle have shown that the administration of synthetic progestogens 
resulted in a range of mammary lesions [2]. There is no agreement as to 
the mechanisms ·whereby these steroids induce such lesions, or whether the 
lesions found with the beagle are important in assessing the potential safety 
of a compound for use in other species, such as humans. The hormonal 
activity of the compounds in question interacts closely with other endocrine 
secretions so that it is difficult to dissociate the effects of the hormones 
themselves from the secondary effects of other agents. 
In the process of the chemical iriduction of a tumor, binding of that 
chemical or one of its metabolites to a biological macromolecule seems to 
be the first step [ 3,4] . Good correlations between that binding and carcino-
Abbreviations: E, estrone; EE, ethinylestradiol. 
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genicity have been found with DNA as target molecules rather than with 
RNA or protein [5,6]. A binding of ethinylestradiol and other hormones 
to protein has been measured in vitro and in vivo [7 ,8] but a binding to 
nucleic acidswas detected only in vitro [9--11]. 
Our Iabaratory has specialized in detecting the binding of weak and 
suspect carcinogens to DNA in vivo [12,13], and in this paper we report 
our positiVe findings with tritiated ethinylestradiol (EE) and estrone (E). 
6, 7 -tritiated estrogens were used, because 6 and 7 are relatively inert 
positions in the metabolism [7] and a binding to DNA in the presence of 
rat liver microsomes occured with a retentionofthat label [11]. 
MATERIALS AND METHODS 
Materials 
Reagents without specified distributor were of the highest purity available 
from Merck, Dannstadt, FRG. 
[6,7}H] -E was radiosynthesized by reducing 6-dehydroestrone 
(3-hydroxy-1,3,5(10),6-estratetraen-17-one, 0.154 mmol, Steraloids Inc. 
Wilton, N.H.) according to Merrill and Vernice [14) with 0.14 mmol carrier-
free tritium gas (8 Ci, The Radiochemical Centre, Amersham, U.K.) in 1 ml 
ethyl acetate containing 25.6 mg 10% Pd/C catalyst (Fluka AG, Buchs, 
Switzerland). After 3 h, the remaining educt was reduced with 0.19 mmol 
hydrogen gas. 
[6,7 .. 3H) -EE was prep.ared by treating 17.9 mg .tritiated E with 38.2 mg 
lithiumacetylide (Lithiumacetylid-Aethylendiaminkomplex pract., Fluka 
AG) and separated from the E after treatment with 15.4 mg Girard's reagent 
P (Fluka AG) according to Cooley and Harris (15). 
Purification: lmmediately before use,. the radioactive honnones were 
chromatographed preparatively on silica gel thin layers (DC Alufolien Kiesel-
gel 60F254, 0.2 mm, Merck) with chloroform/ethyl acetate, 4 : 1. The 
hormones were eluted from the appropriate locations (as compared with 
inactive honnones from Serva, Heidelberg, FRG) with ethanol and ether. 
The solvent was blown off with nitrogen and the hormone was redissolved in 
1 ml ethanol, fractions of which were administered to the rats by gavage. 
Control fractions were used for the detennination of the specific activity and 
were rechromatographed. The radiochemical purity was found tobe better 
than 98.8% for EE (0.6% were E) and 99.6% for E. The specific activity 
of these compounds was 32.5 Ci/mmol as measured from liquid scintillation 
counting in a BF 5000 counter (Berthold, Wildbad, FRG) and UV analysis 
[16]. 
Animals 
Fernale rats (SIV-50, Sprague-Dawley-derived) were obtained from the 
Kantonales Tierspital, Zürich, Switzerland. They were fasted the night 
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TABLEI 
INCORPORATION OF RADIOACTIVITY INTO LIVER DNA OF 4 FEMALE RATS, 
8 H AFTER AGAVAGE OF TRITIATED STEROID HORMONE 
Dose administered 
DN A isolated 
Binding index 
J.tg 
mCi 
mmol/kg 
EE 
79 
8.7 
0.00139 
91 
10.0 
0.00154 
E 
56 
6.7 
0.00087 
94 
11.3 
0.00145 
mg 3.3 3.7 7.1 7.3 
gross cpm 296 441 278 605 
J.tmol/molDNA P 1.86. 10-3 2.55 . 10-3 8.18. 1o-• 1.79 · to- 3 
J.tmol/mol DNA P 
mmol/kg 
mean 
1.34 
1.5 
1.65 0.94 1.24 
1.1 
before treatment but had free access to drinking water. The weight ranged 
from 190-240 g. At 11:00 h, the honnone was administered with dose and 
radioactivity as given in Table I. The animals were held in open metabolism 
cages for the collection of urine. After 6 h, they were given 5 ml tap water 
by gavage in order to increase urine production. At 19:00 h, the animals 
were killed by stunning and cervical dislocation, were bled by heart puncture 
and the liver was excised. 
Isolation of DNA. 
DN A was purified according to Markov and Ivanov [ 17] and redissolved 
in 4 ml 0.014 M sodium phosphate buffer, pH 6.8. An aliquot was diluted 
for UV analysis and the bulk quantity was mixed with 10 ml Insta-Gel 
(Packard, Downers Grove, 111.) for liquid scintillation counting. The 
amount of DNA was detennined by assuming an absorbance of 190 for a 1% 
solution at 260 nm. The absorbance ratio 260 nm/230 nm was better than 
2.27 in all DNA samples so that a maximal protein contamination of 0.1% 
can be expected [ 17] . 
Control experiments. 
Background radioactivity of DNA was measured from a rat which was 
held in parallel to the treated ones. The gross count amounted to 21.7 ± 0.6 
cpm from 2.5 mg DNA. 
Non-enzymatic binding of the honnones to DNA was checked by incuba-
ting 3 g of liver, homogenized and denatured in 25 mllysing medium (0.24 
M sodium phosphate, pH 6.8, 8 M urea, 0.01 M EDTA, 1% sodium dodecyl 
sulfate) with 2.7 mCi honnone for 4 h at room temperature. The net count 
after isolation ofthat DNA was 12 cpm from EE and from E. 
Incorporation of tritium from tritiated water (HTO) into liver DNA was 
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detennined 12 h after administrating 10 mCi HTO/kg to control rats by 
stomach tube. The specific radioactivity amounted to 21 dpm/mg DNA. 
RESULTS 
Table I summarizes the experiments performed on the binding of tritiated 
EE and E to rat liver DNA, 8 h afteroral administration of the honnone. 
The control experiment on non-enzymatic incorporation of radioactivity 
into DNA showed that the radioactivity recovered from the main experi-
ments must be covalently bound. Such a binding can occur from a hormone 
molecule, one of its metabolites or from the incorporation of tritium from 
tritiated water. Water could be formed by metabolic oxidation of the triti-
ated carbon atoms 6 or 7, or by the release of a tritium atom during the 
radioactive decay of its neighbor. Analysis of the urine collected after the 
administration of the hormones showed that from EE only 1% of the total 
radioactivity was excreted in the 8-h urine. Four percent of that radio-
activity lyophilized as tritiated water. With estrone, the corresponding 
figures were 3% excreted, 3% of which was tritiated water. The specific 
activity of water in urinewas therefore in the order of 106 dpm/ml, and we 
can assume that the total body water had a similar specific activity. The 
control experiments on the incorporation of tritium from tritiated water 
into DNA were perfonned with a specific activity of" the body water of 
about 3 · 107 dpmjml. The corresponding specific activity in the hormone 
experiments was thirty times lower so that, theore~ically, less than 0. 7 
dpm/mg DN A could be due to that mode of DNA labelling. This is so little 
as compared to the specific activity of DN A from the main experiment that 
our binding values must represent the labelling of DN A with a hormone 
derivative. 
DISCUSSION 
We have demonstrated a covalent binding of EE and E to rat liver DN A 
in vivo. Carcinogenic activities of these - and probably other- estrogens 
could therefore be based also upon their chemical reactivity towards nucleic 
acids and do not necessarily depend upon the hormonal activity. The 
introduction of the ethinyl substituent into the naturally occurring estrone 
enhances the binding capacity slightly, probably due to the fact that the 
metabolic degradation at position 16 is slower in the case of the synthetic 
analogue and Ieads . to an increased fonnation of other, chemically more 
reactive, metabolites. This is in agreement with the in vitro experiments 
[7] where the binding of EE to protein is about twice that of estradiol. 
The bindin:g index found with the honnones is similar to that of benzene 
(1.7, see ref. 12), but about 4 orders of magnitude below those of typical 
liver carcinogens such as aflatoxin B1 [18] or N,N-dimethylnitrosamine 
[19]. For a comparison of different chemieals the binding index gives the 
11umber of molecules which are bound to DNA from an administration of 
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a unit dose of 1 mmol/kg. lf the binding from a specific exposure has to 
be estimated, e.g. for a risk assessment, the effective doseofthat specific 
chemical to which an individual is exposed must also be accounted for. 
Typical exposures to benzene which eventually Iead to leukemia in humans 
amount to grams/day [20] . The exposure to EE as a contraceptive, on the 
other hand, is only about 50 p.gjday. 
The darnage expected from the natural estrogens is similar to the one 
found from the use of the ethinyl derivative: A woman produces an average 
of a few 100 p.gjday while towards the end of a pregnancy, this production 
increases by more than a factor of 100. 
This quantitative discussion of binding and presumptive carcinogenic risk 
is still very tentative. Additional data are required on the mutagenic potency 
of a specific type of darnage to the DNA as weil as a measure of the repair 
of the DNA in the target organ. Nevertheless, EE and E should be equal in 
this respect so that on the basis of our findings we can deduce that E and its 
ethinyl derivative should not differ much with regards to a suspected 
chemical carcinogenicity. 
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